| Autor: |
Dedov II; Endocrinology Research Centre., Zubkova NA; Endocrinology Research Centre., Arbatskaya NY; Moscow city clinical hospital #1 n.a. N.I.Pirogov., Akopova AG; Moscow City diabetology center., Tyul'pakov AN; Endocrinology Research Centre. |
| Jazyk: |
ruština |
| Zdroj: |
Problemy endokrinologii [Probl Endokrinol (Mosk)] 2009 Jun 15; Vol. 55 (3), pp. 3-7. Date of Electronic Publication: 2009 Jun 15. |
| DOI: |
10.14341/probl20095533-7 |
| Abstrakt: |
Maturity-onset diabetes of the young (MODY) is a clinically heterogenic group of diseases, with an autosomal dominant mode of inheritance and gene mutations resulting in dysfunction of pancreatic β cells. The type of diabetes and further treatment policy can be reliably determined on the basis of the data of a molecular genetic study that confirms gene mutations. Today there are known mutations of 8 genes, of which glucokinase (GCK) gene mutation that leads to the development of MODY2 and occurs most frequently. The spread of this mutation among DM patients in our country has not been studied. The diagnosis of MODY2 was established in 13 members of 5 families with the clinical picture typical of this type. The molecular genetic study revealed 4 new and 1 earlier described mutations. The findings extend ideas on the molecular bases of MODY, which creates conditions for improving the diagnosis of this disease, genetic counseling and the development of pathogenetically founded approaches to treatment. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
